Zentek (ZTEK) Cash from Investing Activities (2021 - 2022)

Zentek's (ZTEK) quarterly Cash from Investing Activities came in at -$680574.7 in Q2 2022, down 443.69% year-on-year from $198019.8 in Q2 2021, and down 443.69% quarter-over-quarter from $198019.8 in Q2 2021.

Zentek (ZTEK) Cash from Investing Activities (2021 - 2022) Analysis & Trends

Zentek has disclosed Cash from Investing Activities across 2 years of filings, most recently posting -$680574.7 for Q2 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn -914.50 Mn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn -139.00 Mn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn -96.00 Mn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn -58.03 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn -42.70 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn -77.00 Mn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn -90.00 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn -131.58 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn -133.00 Mn
10 Zentek - - -17,861.19 -

Historic Data

Download Data
DateValue
Jun 30, 2022 -680,574.74
Jun 30, 2022 -680,574.74
Jun 30, 2021 198,019.83
Jun 30, 2021 198,019.83